On Invalid Date, Apogee Therapeutics (NASDAQ: APGE) reported Q4 2023 earnings per share (EPS) of -$0.32, up 138.1% year over year. Total Apogee Therapeutics earnings for the quarter were -$31.74 million. In the same quarter last year, Apogee Therapeutics's earnings per share (EPS) was $0.84.
As of Q2 2024, Apogee Therapeutics's earnings has grown year over year. Apogee Therapeutics's earnings in the past year totalled -$83.99 million.
What was APGE's revenue last quarter?
On Invalid Date, Apogee Therapeutics (NASDAQ: APGE) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Apogee Therapeutics's revenue was $0.00.
What was APGE's revenue growth in the past year?
As of Q2 2024, Apogee Therapeutics's revenue has grown null year over year. Apogee Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.